Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endra Life Sciences Inc (NDRA)

Endra Life Sciences Inc (NDRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,109
  • Shares Outstanding, K 16,371
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,310 K
  • 60-Month Beta 1.77
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.42
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.95
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/14/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.31
  • Growth Rate Est. (year over year) +322,358.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8600 +13.20%
on 07/14/20
1.0900 -10.69%
on 07/24/20
+0.0735 (+8.17%)
since 07/07/20
3-Month
0.6000 +62.25%
on 05/13/20
1.1700 -16.79%
on 06/19/20
+0.2375 (+32.27%)
since 05/07/20
52-Week
0.5990 +62.52%
on 04/06/20
2.2500 -56.73%
on 01/06/20
-0.4265 (-30.46%)
since 08/07/19

Most Recent Stories

More News
ENDRA Life Sciences to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Monday, August 17, 2020 at 4:30 p.m. ET

ANN ARBOR, MI / ACCESSWIRE / August 5, 2020 / ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that its second quarter financial results will be released...

NDRA : 0.9735 (-1.07%)
ENDRA Life Sciences Mourns the Passing of Board Member Sanjiv Gambhir

ANN ARBOR, MI / ACCESSWIRE / July 23, 2020 / (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®) is mourning the loss of Sanjiv "Sam" Gambhir, M.D, Ph.D, a member of...

NDRA : 0.9735 (-1.07%)
ENDRA Life Sciences Granted Additional European Patent As Commercialization Begins

New grant expands coverage of key U.S. platform patent to Europe

NDRA : 0.9735 (-1.07%)
ENDRA Life Sciences Expands Global Technology Protection With New Chinese Patents

Grants further protect ENDRA's TAEUS® platform capabilities in key international market with over 400 million potential NAFLD patients

NDRA : 0.9735 (-1.07%)
ENDRA Life Sciences Expands IP Portfolio to 72 with Addition of Key Patents

Two Newly Issued Patents Further Protect ENDRA's TAEUS Platform Capabilities

NDRA : 0.9735 (-1.07%)
ENDRA Life Sciences to Present at the 2020 Virtual Summer Summit

ANN ARBOR, MI / ACCESSWIRE / June 8, 2020 / ("ENDRA") (NASDAQ:NDRA), the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that management will present at the , which is being...

NDRA : 0.9735 (-1.07%)
ENDRA Life Sciences Announces New Clinical Study Partnership with the Medical College of Wisconsin (MCW)

Study to Bolster Clinical Evidence of Performance of Patented TAEUS Ultrasound Device in NAFLD Patients as Commercialization Begins

NDRA : 0.9735 (-1.07%)
47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th

The Virtual Summer Summit will take place on June 9-12, connecting 47 presenting small and microcap companies with distinguished investors from around the globe. A full list of issuers are listed below...

ACCO : 7.01 (-0.43%)
ALIM : 6.31 (-8.28%)
ANVS : 5.55 (-2.12%)
AQB : 2.51 (-17.97%)
ARTL : 1.2499 (-0.01%)
AVLNF : 0.0640 (+9.40%)
BLCM : 7.06 (-5.74%)
NDRA : 0.9735 (-1.07%)
EFOI : 6.60 (+8.91%)
EQ : 9.48 (-2.77%)
EXROF : 0.6930 (+0.93%)
HL : 6.12 (-7.97%)
HSII : 21.24 (+5.10%)
HSDT : 0.5351 (-6.12%)
HGBL : 2.7700 (unch)
IPWR : 7.01 (-2.50%)
LINC : 5.23 (-7.10%)
MBII : 1.3400 (+13.56%)
MLSS : 1.8800 (-2.08%)
MYSZ : 1.2900 (+1.57%)
NBEV : 2.42 (+5.68%)
ONCS : 4.01 (-4.52%)
OGEN : 1.0600 (-0.93%)
SFE : 6.27 (+4.50%)
SLS : 3.42 (-2.56%)
PIXY : 4.77 (-0.63%)
SGLB : 2.74 (-2.14%)
SOTK : 3.1000 (+3.68%)
TNXP : 1.1600 (-3.33%)
TGA : 0.6000 (-0.84%)
URG : 0.5400 (-2.37%)
ENDRA Life Sciences Provides Business Update and Reports First Quarter 2020 Financial Results

ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today provided a business update and reported first quarter 2020 financial results.

GE : 6.40 (+1.11%)
NDRA : 0.9735 (-1.07%)
ENDRA Life Sciences Strengthens IP Portfolio with Issuance of Additional Patents for its Innovative Fatty Liver Imaging Probe

ANN ARBOR, MI / ACCESSWIRE / May 6, 2020 / (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), has recently been issued design patents D883487 and D883488 from the...

NDRA : 0.9735 (-1.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade NDRA with:

Business Summary

ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States.

See More

Key Turning Points

2nd Resistance Point 1.0212
1st Resistance Point 0.9973
Last Price 0.9735
1st Support Level 0.9523
2nd Support Level 0.9312

See More

52-Week High 2.2500
Fibonacci 61.8% 1.6193
Fibonacci 50% 1.4245
Fibonacci 38.2% 1.2297
Last Price 0.9735
52-Week Low 0.5990

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar